| Filip Babnic, MD | |
|
Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 | |
| (313) 916-9106 | |
| (313) 916-1249 |
| Full Name | Filip Babnic |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 32 Years |
| Location | Henry Ford Health System, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447328976 | NPI | - | NPPES |
| 700H262220 | Other | BLUE CROSS-BLUE CROSS | |
| FB065524 | Other | CHAMPUS-CHAMPUS | |
| FB065524 | Other | COMMERCIAL-COMMERCIAL NUMBER | |
| 459697410 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 47510 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital | Grand junction, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Colorado West Healthcare System | 3971491887 | 30 |
News Archive
The Department of Health and Human Services and Florida officials negotiate changes to the state's Medicaid plan. In the meantime, Arkansas doctors offer a cautious endorsement as the state tries "episodic" payments for some common conditions.
The parasitology team at the "Severo Ochoa" Molecular biology centre (CSIC-UAM) has focused its research efforts on the search for a vaccine capable of activating immunity against the parasite that causes leishmaniasis.
Research by an Iowa State University scientist suggests that cholesterol-reducing drugs known as statins may lessen brain function.
Roche announced today that it is proposing to acquire all outstanding shares of Illumina, Inc. for $44.50 per share in cash, or an aggregate of approximately $5.7 billion on a fully diluted basis.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announces positive results from a recently completed clinical trial demonstrating the activity of GFT505 on glucose homeostasis. Results from the clinical trial (GFT505-2094) clearly demonstrate the potential of the drug candidate to reduce global cardiovascular risk in prediabetic patients who suffer from impaired fasting plasma glucose, impaired glucose tolerance, and abdominal obesity.
› Verified 8 days ago
| Entity Name | Colorado West Healthcare System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497723407 PECOS PAC ID: 3971491887 Enrollment ID: O20040310000712 |
News Archive
The Department of Health and Human Services and Florida officials negotiate changes to the state's Medicaid plan. In the meantime, Arkansas doctors offer a cautious endorsement as the state tries "episodic" payments for some common conditions.
The parasitology team at the "Severo Ochoa" Molecular biology centre (CSIC-UAM) has focused its research efforts on the search for a vaccine capable of activating immunity against the parasite that causes leishmaniasis.
Research by an Iowa State University scientist suggests that cholesterol-reducing drugs known as statins may lessen brain function.
Roche announced today that it is proposing to acquire all outstanding shares of Illumina, Inc. for $44.50 per share in cash, or an aggregate of approximately $5.7 billion on a fully diluted basis.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announces positive results from a recently completed clinical trial demonstrating the activity of GFT505 on glucose homeostasis. Results from the clinical trial (GFT505-2094) clearly demonstrate the potential of the drug candidate to reduce global cardiovascular risk in prediabetic patients who suffer from impaired fasting plasma glucose, impaired glucose tolerance, and abdominal obesity.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Filip Babnic, MD Po Box 1687, Grand Junction, CO 81502-1687 Ph: (970) 285-6200 | Filip Babnic, MD Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 Ph: (313) 916-9106 |
News Archive
The Department of Health and Human Services and Florida officials negotiate changes to the state's Medicaid plan. In the meantime, Arkansas doctors offer a cautious endorsement as the state tries "episodic" payments for some common conditions.
The parasitology team at the "Severo Ochoa" Molecular biology centre (CSIC-UAM) has focused its research efforts on the search for a vaccine capable of activating immunity against the parasite that causes leishmaniasis.
Research by an Iowa State University scientist suggests that cholesterol-reducing drugs known as statins may lessen brain function.
Roche announced today that it is proposing to acquire all outstanding shares of Illumina, Inc. for $44.50 per share in cash, or an aggregate of approximately $5.7 billion on a fully diluted basis.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announces positive results from a recently completed clinical trial demonstrating the activity of GFT505 on glucose homeostasis. Results from the clinical trial (GFT505-2094) clearly demonstrate the potential of the drug candidate to reduce global cardiovascular risk in prediabetic patients who suffer from impaired fasting plasma glucose, impaired glucose tolerance, and abdominal obesity.
› Verified 8 days ago
Ayman Founas, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Cfp-417, Detroit, MI 48202 Phone: 313-916-2600 | |
Dr. Mohammad Mustafa Qaqi, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 6071 W Outer Dr, Detroit, MI 48235 Phone: 313-966-3189 | |
Dr. Kaled Bazzi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Department Of Internal Medicine, Detroit, MI 48202 Phone: 313-916-1828 | |
Garrett Clark Martin, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 13901 E Jefferson Ave, Detroit, MI 48215 Phone: 313-822-0900 Fax: 313-822-0950 | |
Dr. Prathyusha Savarapu, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-8144 Fax: 313-916-4460 | |
Ibrahim Husham Mohammed, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 Fax: 313-916-4460 | |
Ibrahim Mohamed Abdullah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-1888 |